Chinese Journal of Integrative Medicine

, Volume 17, Issue 2, pp 85–87 | Cite as

Traditional Japanese medicine, Kampo: Its history and current status

Feature Article

Abstract

Traditional Japanese medicine, Kampo, is used by over 80% of medical doctors in Japan. Owing to its high quality and safety, Kampo has been integrated into modern medicine, and there are 345 randomized controlled trials using Kampo in Japan as of 2010. Although there are a number of articles in top journals about basic science research, we can find only small numbers of high-quality clinical evidence. Since undergraduate education on Kampo has been established, integrative approach with the balanced combination of modern medicine and Kampo is expected to generate good clinical evidence in the near future.

Keywords

Kampo traditional medicine evidence randomized controlled trial integrative medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tsutani K. The evaluation of herbal medicines: an east Asian perspective. In: Lewith GT, Aldridge D, eds. Clinical research methodology for complementary therapies. London: Hodder & Stoughton;1993:365–393.Google Scholar
  2. 2.
  3. 3.
    Motoo Y, Arai L, Hyodo I. Tsutani K. Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines. Complement Ther Med 2009;17:147–154.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen KJ, Jiang YR. Current status and problems in developing clinical guidelines for Chinese medicine and integrative medicine. J Chin Integr Med 2009;7:301–305.CrossRefGoogle Scholar
  5. 5.
    Lai SL, Wu DR, Lao YR. Scientific principles and rigorous processes should be followed in developing clinical guidelines for therapeutic interventions of integrative medicine. Chin J Integr Med 2008;14:3–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008;134:2004–2013.PubMedCrossRefGoogle Scholar
  7. 7.
    Yakabi K, Kurosawa S, Tamai M, Yuzurihara M, Nahata M, et al. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction. Regul Pept 2010;161:97–105.PubMedCrossRefGoogle Scholar
  8. 8.
  9. 9.
    Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7:e1000217.PubMedCrossRefGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Yoshiharu Motoo
    • 1
    • 2
  • Takashi Seki
    • 1
    • 3
  • Kiichiro Tsutani
    • 1
    • 4
  1. 1.The Japan Society for Oriental MedicineTokyoJapan
  2. 2.Department of Medical OncologyKanazawa Medical UniversityUchinada, IshikawaJapan
  3. 3.Department of Traditional Asian MedicineTohoku University Graduate School of MedicineSendaiJapan
  4. 4.Department of Drug Policy and Management, Graduate School of Pharmaceutical SciencesThe University of TokyoTokyoJapan

Personalised recommendations